The findings revealed that diminished expression of TGFB1 and heightened expression of LAT, IFNG, and IL17F were significantly correlated with an improved prognosis in patients with HNSCC (Fig. 5F). The gene discussed is TGFB1; the disease is head and neck squamous cell carcinoma.